{"id":"W2956922241","doi":"10.1111/jdv.15793","title":"Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase‐3, randomized, placebo‐controlled trial","year":2019,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"AbbVie","keywords":"Medicine; Adalimumab; Placebo; Psoriasis; Dermatology; Nail (fastener); Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005989373,0.00173336,0.003411975,0.0005192326,0.000947857,0.001407777,0.001011874,0.00224349,0.009401384],"category_scores_gemma":[0.003485441,0.0007201429,0.002784936,0.000631706,0.0009674822,0.0010586,0.0004748511,0.002333112,0.001354445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007647859,"about_ca_system_score_gemma":0.001810668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006071606,"about_ca_topic_score_gemma":0.001520637,"domain_scores_codex":[0.9976483,0.001265622,0.0002120619,0.0004061937,0.00023322,0.0002345704],"domain_scores_gemma":[0.997857,0.0005954556,0.0006016918,0.0001969601,0.0001974647,0.0005513948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9652344,0.005895415,0.0006499565,0.001377838,0.001314457,0.00004444812,0.00004154157,0.0001506735,0.002060968,0.00006566312,0.001071868,0.02209278],"study_design_scores_gemma":[0.9708955,0.02670984,0.001231541,0.00006311468,0.0003747249,0.00002216721,0.00000639917,0.0000782276,0.0001422456,0.00004851665,0.0004206004,0.000007060036],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.934949,0.03021177,0.002283792,0.001637446,0.00130728,0.02089453,0.003277825,0.0003776542,0.005060862],"genre_scores_gemma":[0.954262,0.01269351,0.003215354,0.002998372,0.001299764,0.01947736,0.002037803,0.00005995546,0.003955858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009401384,"threshold_uncertainty_score":0.03167522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01374117553980937,"score_gpt":0.2626512666596356,"score_spread":0.2489100911198263,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}